Navigation Links
Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors

3rd Annual Meeting

CHICAGO, Ill., June 2, 2007 - Pharmion Corporation (NASDAQ: PHRM) today reported data from a pilot study that demonstrated the bioavailability of the Company's oral dosage formulation of Azacitidine. These data were presented at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. (June 1-5, 2007). Pharmion's epigenetic anti-cancer products, which include Vidaza(r) (azacitidine for injection), MCGD0103 and oral Azacitidine, are being investigated in the treatment of hematologic malignancies and solid tumors and are the subject of poster and oral presentations at the Meeting.

An oral dosage formulation of Azacitidine would provide a more desirable and convenient route of administration for patients and clinical staff and eliminate injection-site reactions. In addition, it would enable the evaluation of a low-dose regimen that could maximize demethylation and gene re-expression, as well as the evaluation of long-term or maintenance therapy.

The study was designed to assess the safety, tolerability, and pharmacokinetics of escalating single doses of orally administered Azacitidine in patients with Myelodysplastic Syndromes (MDS), acute myeloid leukemia (AML) or other solid tumors. A total of four patients were enrolled and received study drug. One patient received a 60 mg dose and three patients received a single 80 mg dose. In each case, Azacitidine was well-tolerated and quantifiable in plasma. Following an 80mg dose the bioavailability of the oral formulation of Azacitidine was 18 percent relative to subcutaneous (SC) administered Vidaza. Having established that acceptable plasma concentrations of azacitidine can be achieved with single oral dosing, this pilot study has concluded. A multi-dose escalating study of oral azacitidine is now underway.

"Oral azacitidine represents an extremely exciting opportunity," said Dr. Guillermo Garcia-Manero, Associate Professor of Medicine and Chief,
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:12/17/2014)... NEW YORK , Dec. 17, 2014 /PRNewswire-USNewswire/ ... resonance imaging (MRI), the MRI market is seeing ... cardiovascular and breast MRI scans account for the ... providing a higher resolution of images, which are creating ... resonance imaging (MRI) market is growing at a ...
(Date:12/17/2014)... 2014  IGI Laboratories, Inc. (NYSE MKT: IG; "IGI" ... offering of $125 million aggregate principal amount of 3.75% ... were offered and sold only to qualified institutional buyers ... 1933, as amended (the "Securities Act"). The ... per year, payable semiannually in arrears on June 15 ...
(Date:12/15/2014)... December 15, 2014 ... 19. und 20. Februar sind alle akkreditierten ... MEDICINE ECOSYSTEM PARTNER PROGRAMM ™ 2015 in ... Diese Tagung soll dazu beitragen, ... geben, die neue profitablen Unternehmensdienstleistungen, die für ...
Breaking Medicine Technology:Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2
... 12, 2007,/PRNewswire-FirstCall/ -- Data analyses from the ... in the renal,anemia arena provide efficacy and ... for the treatment of,renal anemia associated with ... and not on dialysis. Three data analyses ...
... * Glivec found to dramatically reduce the risk ... (GIST) , * Patients receiving placebo in this ... regulatory submissions planned for use of Glivec as,adjuvant ... tumor , * Glivec already approved as effective ...
Cached Medicine Technology:Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 2Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 3Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 4Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 2Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 3Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 4Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 5Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 6
(Date:12/21/2014)... Theme and plugin developers ... plugin for Final Cut Pro X entitled ProMotion. , ... more with absolute ease.” Said Christiana Austin, CEO of ... needed to easily animate their media inside FCPX.” , ... users to animate pictures, videos, logos, and more with ...
(Date:12/20/2014)... BambooIndustry.com is a professional company offering ... has recently shown its new engineered bamboo flooring collection, ... flooring models. , BambooIndustry.com’s customers come from many countries ... According to the CEO of the company, the global ... the past few years, and the demand for eco-friendly ...
(Date:12/20/2014)... 20, 2014 Dress company LunaDress has recently ... announced its Christmas Sale, offering big discounts on all of ... has an idea to own a perfect wedding gown. If ... wedding dress, then come to LunaDress. Many different wedding dress ... Visit our website now and enjoy the current special offer, ...
(Date:12/20/2014)... Doctor’s Office Urgent Care of Paramus, New Jersey has served ... They’ve treated over 40,000 patients while carrying out their mission ... the Paramus area. , For 2015, the practice is ... top-notch board certified physicians: Christine Milosis MD, Sandra Ugras Rey ... will work tirelessly to carry out The Doctor’s Office ...
(Date:12/20/2014)... Recently, AngelWeddingDress.com has introduced its special offer ... coming Christmas. In the promotion, all buyers worldwide can ... have something special for the women who are looking ... our new collections of 2015 dresses have been unveiled ... greatly discounted prices. Visit our website now before they ...
Breaking Medicine News(10 mins):Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2Health News:BammbooIndustry.com: Big Discounts On All Kinds Of Bamboo Flooring Collections 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2
... new ways of controlling and treating breast cancer at ... (Monday 1 October 2007). , Dr Robert Clarke and ... have been investigating human breast cancers for the presence ... and can cause the cancer to recur - in ...
... 1 In honor of October, Breast Cancer,Awareness Month, ... the Cure,encourages San Diegans to participate in a number ... Komen for the Cure can help the,organization in its ... awareness in San Diego County. "We encourage all ...
... on Spotting Depression in Children, BETHLEHEM, Pa., Oct. ... by depression each year, but even as thousands of,sites ... and educate them,about the condition on National Depression Screening ... a largely overlooked part of our,population: children. In ...
... Jobs With ... Congressman Rodney Frelinghuysen, PARSIPPANY, N.J., Oct. 1 ... and rapidly increasing its,staffing since 2002 to support a growing ... Sankyo is,one of the few pharmaceutical companies experiencing steady and ...
... raise funds,through in-store ,pin-up, campaign, ALEXANDRIA, Va., Oct. ... Kmart has reinforced its,commitment to ADA and elevated its ... Partner (NSP). As a National Strategic,Partner, Kmart will raise ... and cure diabetes, and to improve the lives of ...
... bug busting approach to head lice is helping to reduce ... to a review in the October issue of Journal of ... Hygiene Concern led a review of studies carried out in ... The best results are obtained when parents are supplied with ...
Cached Medicine News:Health News:Manchester researchers announce new methods of beating breast cancer 2Health News:In Celebration of Breast Cancer Awareness Month, Susan G. Komen for the Cure San Diego Announces Opportunities for San Diegans to Get Involved in the Fight Against Breast Cancer 2Health News:In Celebration of Breast Cancer Awareness Month, Susan G. Komen for the Cure San Diego Announces Opportunities for San Diegans to Get Involved in the Fight Against Breast Cancer 3Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 2Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 3Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 4Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 5Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 2Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 3Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 4Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 5Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 6Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 7Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 8Health News:Kmart Steps Out to Fight Diabetes 2Health News:Kmart Steps Out to Fight Diabetes 3Health News:Multicountry review shows that Bug Buster Kits reduce head lice and social stigma 2Health News:Multicountry review shows that Bug Buster Kits reduce head lice and social stigma 3
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: